Infigratinib in Subjects With GC or GEJ With FGFR2 Amplification or Other Solid Tumors With Other FGFR Alterations

Clinical trial NCT05019794 · UNKNOWN

Trial details

NCT number: NCT05019794
Sponsor: LianBio LLC
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Gastric Cancer Gastroesophageal Junction Adenocarcinoma Solid Tumor

Start date: 2020-05-13
Primary completion: 2022-12-30
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.